LIXT
Lixte Biotechnology Holdings Inc
3.70$
-1.3%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +28.1% | +3.9% | -79.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -35.9% | +30.6% | -78.5% | +27.5% | +396.3% | -88.3% | +693.4% | -41.9% | -47.8% | -75.4% | +1,011.3% | -4.7% | +67.1% | +107.7% | -40.5% | -50.0% | -45.9% | +272.8% | |
| – | – | – | – | – | – | – | – | – | – | -45.4% | -62.0% | -75.4% | +1,011.3% | -4.7% | +67.1% | +107.7% | -40.5% | – | – | – | |
| – | – | – | +2,626.0% | -66.9% | -939.2% | – | -138.7% | – | -434.7% | – | – | +91.4% | -150.2% | – | -772.1% | – | – | -86.7% | -85.4% | +13,630.6% | |
| – | – | -45.4% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | +25.0% | -40.0% | +66.7% | -20.0% | -100.0% | |
| – | – | – | – | – | +6,204.0% | – | -72.4% | – | – | – | -5.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | -815.1% | -44.7% | – | – | – | -99.1% | +24,900.0% | – | – | +46.2% | -15.3% | +43.9% | -101.0% | – | – | – | – | – | – | – | |
| – | +2,883.0% | -52.5% | -81.2% | +2,097.1% | -50.5% | -99.5% | +49,931.7% | +0.0% | -43.5% | +45.3% | -14.8% | +44.1% | +77.9% | +2.8% | +0.0% | -15.3% | +31.9% | -38.9% | -100.0% | – | |
| – | +14,469.1% | -125.4% | – | – | -192.9% | – | – | -171.9% | – | – | – | +533.2% | +168.3% | -156.4% | – | -109.9% | – | -317.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.